Back to mobile site

Globus Medical (GMED) PT Raised to $30 at BofA/Merrill Lynch Following Q4, Branch Deal

February 26, 2015 8:37 AM EST Send to a Friend
BofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and boosted his price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login